Tomoyasu Jo, Tomoaki Ueda, Yu Akahoshi, Tadakazu Kondo, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Noriko Doki, Shuichi Ota, Masashi Sawa, et al. First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia. British Journal of Haematology. 2024. 204. 5. 1913-1919
Yo Mizutani, Shinsuke Kusakabe, Kentaro Fukushima, Hiraku Murakami, Masataka Hamada, Chihiro Hasegawa, Emiko Mizuta, Yuta Yamaguchi, Ritsuko Nakai, Ryumei Kurashige, et al. [Sequential therapy with inotuzumab ozogamicin followed by CAR T-cell therapy for Philadelphia chromosome-negative acute lymphoblastic leukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2024. 65. 2. 78-83
Tomoaki Ueda, Jiro Fujita, Yasuhiro Akazawa, Ai Kawamura, Takahiro Matsui, Akihisa Hino, Shinsuke Kusakabe, Takao Sudo, Kentaro Fukushima, Takafumi Yokota, et al. Successful Bridging to Allogeneic Hematopoietic Stem Cell Transplantation by Azacitidine and Venetoclax in a Case of Acute Myeloid Leukemia With t(3;3)(q21.3;q26.2) Developed Early After Orthotopic Heart Transplantation. Transplantation Proceedings. 2023. 55. 3. 711-714
Ayami Senda, Hideaki Saito, Shinsuke Kusakabe, Koki Yoshida, Kumi Shibata, Shuhei Kida, Jun Toda, Akihisa Hino, Tomoaki Ueda, Jiro Fujita, et al. [Acquired hemophilia A following BNT162b2 mRNA COVID-19 vaccination]. [Rinsho ketsueki] The Japanese journal of clinical hematology. 2023. 64. 1. 35-41
水谷陽, 草壁信輔, 福島健太郎, 村上拓, 濱田雅隆, 長谷川千紘, 水田惠美子, 山口優太, 中井りつこ, 倉重隆明, et al. Sequential therapy of Inotuzumab ozogamicin and CAR-T for Ph-negative acute lymphoblastic leukemia. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2024. 46th
竹原経子, 福島健太郎, 水谷陽, 長谷川千紘, 水田恵美子, 山口優太, 倉重隆明, 中井りつこ, 日野彬央, 草壁真輔, et al. Evaluation of quality of life and symptoms after hematopoietic stem cell transplantation. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2024. 46th
水田惠美子, 福島健太郎, 濱田雅隆, 水谷陽, 長谷川千紘, 山口優太, 中井りつ子, 倉重隆明, 日野彬央, 草壁信輔, et al. Analysis of HSCT for myelofibrosis treated with pre-and post-transplant ruxolitinib. 日本造血・免疫細胞療法学会総会プログラム・抄録集. 2024. 46th
2014 - 2020 Osaka University Graduate School of Medicine Division of Medicine
2001 - 2007 Osaka University Faculty of Medicine Medical School
Professional career (1)：
医学博士 (大阪大学)
Work history (5)：
2021/04 - 現在 Osaka University Graduate School of Medicine
2014/04 - 2021/03 Osaka University Hospital
2012/04 - 2014/03 倉敷中央病院 血液内科 専門修練医
2009/04 - 2012/03 倉敷中央病院 血液内科 後期研修医
2007/04 - 2009/03 住友病院 総合診療科 初期研修医
Awards (2)：
2018/12 - American Society of Hematology Abstract Achievement Award ESAM on the cells of endothelial lineage plays an important role in the development of definitive hematopoiesis
2016/12 - American Society of Hematology Abstract Achievement Award Endothelial Cell-Selective Adhesion Molecule (ESAM) Is Required for the Ontogeny of Definitive Hematopoietic System in Mice
Association Membership(s) (6)：
THE JAPAN SOCIETY OF TRANSFUSION MEDICINE AND CELL THERAPY
, 日本臨床腫瘍学会
, Japanese Society for Transplantation and Cellular Therapy
, THE JAPANESE SOCIETY OF HEMATOLOGY
, THE JAPANESE SOCIETY OF INTERNAL MEDICINE
, 日本移植学会
